James P. Kiley
Director
The National Heart, Lung, and Blood Institute (NHLBI) has launched a clinical trial to study the safety and effectiveness of the anti-malarial drug hydroxychloroquine for treating COVID-19.
A new study found that long-term exposure to air pollution is strongly linked to emphysema, a deadly lung disease often associated with smoking.